Infectious endocarditis caused by Haemophilus parainfluenza

Authors

  • Natália Totti Martins Instituto de Infectologia Emilio Ribas - São Paulo - SP - Brasil
  • Aline Santos Ibanes Instituto de Infectologia Emilio Ribas - São Paulo - SP - Brasil
  • Victor Garcia Nunez Instituto de Infectologia Emilio Ribas - São Paulo - SP - Brasil
  • Victória Spinola Duarte de Oliveira Instituto de Infectologia Emilio Ribas - São Paulo - SP - Brasil

DOI:

https://doi.org/10.5935/2764-734X.e20240236

Keywords:

Endocarditis, Bacterial, Haemophilus Infections, Haemophilus parainfluenzae, Case Reports

Abstract

Infective endocarditis caused by bacteria from the HACEK group - Haemophilus spp. (excluding Haemophilus influenza), Aggregatibacter actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens and Kingella kingae - is rare; affected patients are usually young and present with predisposing factors, such as heart disease. The infection is characterized by an insidious clinical course of subacute presentation, with an average delay in diagnosis of one to three months, which may be related to the formation of larger valve vegetations and a consequent increased risk of embolization. This report describes a case of a young, previously healthy girl whose primary clinical complaint was headache and fever. The diagnostic suspicion arose after Haemophilus parainfluenza positive blood culture and was confirmed by the echocardiographic visualization of a vegetation adhering to the posterior leaflet of the mitral valve. There was a good clinical response to treatment with ceftriaxone for six weeks; however, after three months, surgery for valve replacement was necessary.

References

1932-5

2. Chambers ST, Murdoch D, Morris A, Holland D, Pappas P, Almela M, et al. HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort. PLoS One. 2013;8(5):e63181. DOI: 10.1371/journal.pone.0063181

3. Ferro JM, Fonseca AC. Infective endocarditis. Handb Clin Neurol. 2014;119:75-91. DOI: 10.1016/B978-0-7020-4086-3.00007-2

4. Delgado V, Marsan NA, Waha S, Bonaros N, Brida M, Burri H, et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J. 2023;44(39):3948-4042. DOI: 10.1093/eurheartj/ehad193

5. Holland TL, Baddour LM, Bayer AS, Hoen B, Miro JM, Fowler Junior VG. Infective endocarditis. Nat Rev Dis Primers. 2016;2:16059. DOI: 10.1038/nrdp.2016.59

6. Fowler VG, Durack DT, Selton-Suty C, Athan E, Bayer AS, Chamis AL, et al. The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria. Clin Infect Dis. 2023;77(4):518-26. DOI: 10.1093/cid/ciad271

7. Yew HS, Chambers ST, Roberts SA, Holland DJ, Julian KA, Raymond NJ, et al. Association between HACEK bacteraemia and endocarditis. J Med Microbiol. 2014;63(Pt 6):892-5. DOI: 10.1099/jmm.0.070060-0

8. Gagliardi R, Sensi C, Flaminio G, De Canale E, Vettor R, De Carlo E. Haemophilus parainfluenzae endocarditis in a low-risk woman: a case report. Clin Case Rep. 2021;9(11):e05066. DOI: 10.1002/ccr3.5066

9. Baddour LM, Wilson WR, Bayer AS, Fowler Junior VG, Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation 2015;132:1435-86. DOI: 10.1161/CIR.0000000000000296

10. Mohananey D, Mohadjer A, Pettersson G, Navia J, Gordon S, Shrestha N, et al. Association of vegetation size with embolic risk in patients with infective endocarditis: a systematic review and meta-analysis. JAMA Intern Med. 2018;178(4):502-10. DOI: 10.1001/jamainternmed.2017.8653

Downloads

Published

2024-04-30

How to Cite

Martins, N. T., Ibanes, A. S., Nunez, V. G., & Oliveira, V. S. D. de. (2024). Infectious endocarditis caused by Haemophilus parainfluenza. Infections in Evidence, 3, e20240236. https://doi.org/10.5935/2764-734X.e20240236

Issue

Vol. 3 (2024)

Section

Case Reports

License

Copyright (c) 2025 Infections in Evidence

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The Copyright Transfer Agreement assumes that the authors are the legitimate holders of the copyright of the Case Report in question, without infringing any copyright, trademark or patent of others. In this way, they transfer all rights to this manuscript or any revision, version or translation of it to the Journal, including here the exclusivity of its eventual commercialization, provided that in accordance with ethical and moral precepts and relevant Brazilian legislation. All articles in the INFECTIONS IN EVIDENCE Journal are published under the terms of international license 4.0 of the Creative Commons Attribution, which allows users to freely read, download, share and adapt cultural and scientific productions, provided that due credit is given to the original authors and publication.
The Copyright Transfer Agreement also understands that the authors guarantee that the respective Case Report has never been published in another communication vehicle or scientific journal. Papers presented at meetings and/or scientific congresses may be published in the electronic journal INFECTIOUS DISEASES IN EVIDENCE - Case Reports, provided that they have not been published in whole or in part in their Proceedings or Annals.